Table 3.

Summary statistics for the percentage of children with documented evidence and percent coverage for DTP1, DTP3 and MCV1 among 66 survey dyads comprised by an EPI coverage survey and a non-EPI survey separated by no more than 12 months during 2000–2019.

	EPI				Non-EPI				Dyads with data*	# dyads with EPI value < non-EPI value	# dyads with EPI > non-EPI by
	# surveys	min/max	mean (SD)	median (IQR)	# surveys	min/max	mean (SD)	median (IQR)			≤5%-pts	>5%-pts	>10%-pts
Documented evidence available to be seen, %	62	11/100	72 (20.8)	77 (58,87)	63	12/100	63 (20.9)	68 (49,74)	59	7	3	49	35
DTP1 by D, %	45	10/99	69 (23.5)	77 (54,84)	59	17/99	63 (19.5)	67 (52,75)	41	9	3	29	19
DTP3 by D, %	46	9/98	63 (24.3)	68 (47,81)	59	10/99	56 (20.5)	58 (47,70)	42	10	1	31	18
MCV1 by D, %	46	9/99	60 (23.9)	64 (42,78)	59	14/99	53 (20.2)	56 (43,66)	42	7	7	28	19
DTP1 by D + R, %	60	43/100	89 (10.2)	92 (85,97)	66	43/100	85 (15.0)	90 (82,95)	60	11	28	21	12
DTP3 by D + R, %	63	25/100	81 (14.5)	82 (73,93)	66	21/100	71 (19.4)	73 (64,87)	63	8	12	43	28
MCV1 by D + R, %	63	25/100	78 (14.0)	78 (71,90)	66	27/100	73 (16.3)	76 (67,85)	63	18	15	30	16

D, documented evidence of vaccination history.

D + R, combination of documented evidence of vaccination or respondent recall of child’s vaccination history in absence of documented evidence.

EPI, Expanded Programme on Immunization Survey.

non-EPI survey = DHS/MICS/OCS.

DTP1, first dose of diphtheria-tetanus toxoid-pertussis containing vaccine.

DTP3, third dose of diphtheria-tetanus toxoid-pertussis containing vaccine.

MCV1, first dose of measles containing vaccine.

min, minimum.

max, maximum.

SD, standard deviation.

IQR, inter-quartile range.

^*Number of dyads where both EPI and non-EPI surveys reported information for the particular measure.